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a b s t r a c t
P-glycoprotein (Pgp/ABCB1) both accounts for multidrug resistance (MDR) in chemotherapy
and contributes to reduce oral bioavailability and brain distribution of drugs. Flavonoids,
reported as potent Pgp inhibitors, are able to bind to the cytosolic ATP-binding site and a
vicinal hydrophobic pocket. In order to explore the interaction forces governing the afﬁn-
ity of ﬂavonoids towards Pgp, the 3D quantitative structure–activity relationship (QSAR)
approach was used to analyze a set of ﬂavonoid derivatives. The variation of afﬁnity towards
Pgp was investigated by VolSurf descriptors of Molecular Interaction Fields (MIFs) related to
hydrophobic interaction forces, polarizability, andhydrogen-bonding capacity. The 3D linear
solvation energy VolSurf model developed here identiﬁes shape parameters and hydropho-
bicity as the major physicochemical parameters responsible for the afﬁnity of ﬂavonoid3D QSAR
Molecular Interaction Fields
LSER
VolSurf descriptors
derivatives towards Pgp and hydrogen-bonding capacities asminormodulators of this activ-
ity. Furthermore, this predictive model (q2 of 0.71) was also validated by use of an external
set of 10 ﬂavones.
© 2008 Elsevier B.V. Open access under CC BY-NC-ND license.
is able to extrude a large variety of hydrophobic or amphiphilicPgp/ABCB1
1. Introduction
Initially the multidrug resistance (MDR) phenomenon was
observed in the treatment of cancer and afterward in tuber-
culosis, malaria and bacterial and HIV infections (Juliano and
Ling, 1976; Kane, 1996). MDR is mainly due to the over expres-
sion of P-glycoprotein (Pgp/ABCB1), a plasmamembrane efﬂux
transporter coded by the MDR1 gene in humans (Dey et al.,
∗ Corresponding author. Tel.: +41 22 379 33 59; fax: +41 22 379 33 60.
E-mail address: Pierre-alain.Carrupt@unige.ch (P.-A. Carrupt).
0928-0987 © 2008 Elsevier B.V. Open access under CC BY-NC-ND license.
doi:10.1016/j.ejps.2008.09.0091997; Gottesman and Pastan, 1993). Under physiological con-
ditions, the efﬂux protein is present within several tissues
such as kidney, small intestine and blood brain barrierwhere it
plays a detoxiﬁcation function (Schinkel and Jonker, 2003). Pgpdrugs (Collett et al., 1999; Schinkel and Jonker, 2003). Pgp
belongs to the ATP-binding cassette (ABC) superfamily and
share an architecture consisting of two homologous halves,
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ach comprising of a transmembrane domain of six putative
-helices and a cytosolic nucleotide-binding domain (NBD)
or ﬁxing ATP. It has been renamed ABCB1 according to the
ecent Human Genome Organization (HUGO) nomenclature.
everal drug-binding sites partially overlapped have been
haracterized in a pocket localized in the transmembrane
egion (Garrigues et al., 2002). The mechanism of action of
gp remains a subject of controversy (Pajeva and Wiese, 2002;
harom et al., 2005; Stouch and Gudmundsson, 2002). How-
ver the “hydrophobic vacuum cleaner” model appears to
e the most plausible (Rauch and Pluen, 2007). The efﬂux
ump detects compounds localized in the lipidic bilayer and
ejects them on the extracellular side. According to this mech-
nism, the efﬂux of drugs is controlled by their ability to
iffuse through the membrane and thus by their lipophilicity
Camenisch et al., 1996; Stouch and Gudmundsson, 2002). Pgp
ctivity accounts for critical failures in cytotoxic chemother-
py and limits drug oral bioavailability as well as brain
ermeation. In this context, overcoming Pgp-mediated efﬂux
onstitutes an important challenge for medicinal chemists.
ne strategy to restore anti-cancer drug cytoplasmic accu-
ulation is to use Pgp inhibitors, also called modulators or
hemosensitizers.
Concerning the ﬂavonoids, they were reported as a new
lass of bifunctional modulators binding to a site which
artly overlaps the ATP-binding site and a vicinal hydropho-
ic region interacting with steroids within the cytosolic
omain of P-glycoprotein (Pgp) (Conseil et al., 1998). Xan-
hones, ﬂavonoids such as kaempferol, galangin, quercetin
nd their hydrophobic derivatives which modulate drug efﬂux
n MDR cancer cells, bind with similar afﬁnities and rela-
ive efﬁciencies towards puriﬁed cytosolic NBD2 (C-terminal
ucleotide-binding domain) of Pgp (Boumendjel et al., 2002b;
onseil et al., 1998). Perez-Victoria and coworkers suggested
hat only ﬂavonoidswith high afﬁnity for the cytosolic domain
f Pgp are able to increase daunomycin accumulation in Leish-
ania tropica cell lines over expressing the Pgp transporter
Pérez-Victoria et al., 2001).
Quantitative structure–activity relationships (2D or 3D-
SAR) offer adequatemethodologies to identify physicochem-
cal properties which govern biological activities. Comparative
olecular Field Analysis (CoMFA) allows to map Molecular
nteraction Fields (MIFs) surrounding the molecular struc-
ures according to their impact on a given activity. However,
oMFA models are widely dependent on the alignment of
he molecular structures (Martin, 1998). Among the 3D-QSAR
ethods, VolSurf represents an alternative procedure allow-
ng the comparison of MIFs which were speciﬁcally designed
o produce descriptors related to pharmacokinetic (PK) prop-
rties. Alignment of molecules is not required in VolSurf since
he spatial localization and the intensity of molecular interac-
ions encoded by each MIFs is condensed into 1D descriptors
Cruciani et al., 2000). Recently a 3D QSAR method combin-
ng MIFs and VolSurf descriptors was developed (Bajot, 2006)
or the aim of modelling some permeation properties of drug
ompounds.The linear solvation energy relationship (LSER) analysis
as initiated by Taft et al. and used to quantify solute–solvent
nteractions by global descriptors of hydrophobicity, polar-
zability and hydrogen-bonding capacity and correlate theml sc i ences 3 6 ( 2 0 0 9 ) 254–264 255
to many structural or pharmacokinetic properties (Taft et
al., 1985). In the 3D method used here, the physicochemi-
cal properties are represented by four MIFs associated with,
respectively, the hydrophobic part of the molecular lipophilic-
ity potential (MLP) (Gaillard et al., 1994), the acceptor and
donor parts of the molecular H-bonding potential (MHBP) and
the GRID DRY ﬁeld (Rey et al., 2001). This method has allowed
an in-depth analysis of the intermolecular interaction forces
involved in pharmacokinetic mechanisms such as skin per-
meation (Bajot, 2006).
In the present study, this approach was applied to model
the afﬁnity towards Pgp, a pharmacodynamic (PD) pro-
cess strongly inﬂuenced by the physicochemical properties
of compounds. Therefore, the 3D solvatochromic VolSurf
parameters derived from MIFs were used to characterize
the interaction between ﬂavonoids and Pgp and to predict
their afﬁnity for the C-terminal nucleotide-binding domain
NBD2.
2. Material and methods
All calculations have been performed on Silicon Graphics O2
R5000 180-MHz, Origin 2000 4·R10000 195-MHz or PC-LINUX
workstations using several molecular modelling and statisti-
cal softwares, namely SYBYL 7.0molecularmodelling package
(Tripos Associates, St. Louis, MO, USA) including SLN23 (Sybyl
Line Notation) and SPL (Sybyl Program Language), TSAR 3.3
(Oxford Molecular Ltd., Oxford, UK), GRID 2.2 (Molecular Dis-
covery Ltd., Oxford, UK), VOLSURF 4.1.4.3 (Molecular Discovery
Ltd., Oxford, UK), SIMCA 11.1 (Umetrics, Umeå, Sweden),
MATLAB® 7 (The MathWorks, Natick, USA) and the N-Way
Toolbox (Andersson and Bro, 2000).
2.1. Pgp afﬁnity dataset and test sets
The training set containing 89 ﬂavonoid derivatives was
composed of ﬂavones and one isoﬂavone, chalcones, sily-
bins, aurones and xanthones (Tables 1–5) (Boumendjel et
al., 2002a,b). The in vitro binding was evaluated by intrinsic-
ﬂuorescence quenching of the puriﬁed recombinant NBD2 of
Pgp (Di Pietro et al., 2002). The binding afﬁnity was estimated
by determining the dissociation constant Kd and expressed as
the negative logarithm of Kd (M) (Fig. 1).
Biological activity screening of ﬂavonoid derivatives
showed a strong correlation between their in vitro bind-
ing to NBD2 of Leishmania tropica Pgp (Ltrmdr1) and in vivo
MDR-modulating effect in MDR cell line of the parasite (Di
Pietro et al., 2002). Therefore, the model quality was evalu-
ated by use of the inhibitory potency values (pIC50) for 10
ﬂavonoid derivatives external to the training set determined
on daunorubicin-resistant AML-2/D100 cell line in aMTT cyto-
toxicity assay (Choi et al., 2004). Structurally, these additional
compounds are located into the chemical space characterizing
the training set (Fig. 2).2.2. MIFs and VolSurf descriptors
For all compounds, the starting 3D geometry was built
by the Corina algorithm (Sadowski et al., 1994; Sadowski
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Table 1 – Experimental and calculated afﬁnities for chalcone derivatives.
.
Cpd Substituent −logKda −logKd
3 4 2′ 4′ 5′ 6′ Experimental Calculated
1 H OH OH H OH 5.34 5.72
2 H OH OH OH H OH 5.32 5.34
3 H OCH3 OH OH H OH 5.64 5.57
4 H F OH OH H OH 5.44 5.41
5 H Cl OH OH H OH 5.89 5.95
6 H Br OH OH H OH 6.24 6.09
7 H I OH OH H OH 6.60 6.47
8 H C2H5 OH OH H OH 5.68 6.13
9 H C3H7 OH OH H OH 6.00 6.63
10 H C6H13 OH OH H OH 6.57 7.10
11 H C6H11 OH OH H OH 6.28 6.84
12 H C8H17 OH OH H OH 7.70 7.62
13 H C10H21 OH OH H OH 7.22 Not used
14 H C14H29 OH OH H OH 4.85 Not used
15 H Prenyl OH OH H OH 6.28 6.23
16 OH OH OH OH Prenyl OH 6.36 6.25
17 H H OH H H H 5.05 5.53
18 H H OH H DMA H 6.36 6.80
19 H OH OH H H H 4.96 5.15
20 Prenyl H OH H H H 6.28 6.36
21 OCH3 OH H H H 5.74 5.53
22 Prenyl OCH3 OH H
a Taken from Boumendjel et al. (2002a,b).
and Gasteiger, 1993) and bonds’ torsions were oriented to
maximize intra-molecular H-bonding. Then the geometry
of compounds was optimized in SYBYL7.0 using the Merck
Molecular Force Field (MMFF94s) including MMFF94 partial
atomic charges (Halgren, 1999). The acceptor and donor
parts of MHBPs (MHBPac and MHBPdo, respectively) and
the molecular hydrophobicity potential (deﬁned as the pos-
itive part of the molecular lipophilicity potential, MLPho)
were computed using in-house SPL procedures (Gaillard
et al., 1994; Rey et al., 2001) in SYBYL7.0 and imported
in VolSurf (Cruciani et al., 2000) to generate numerical
descriptors. The “DRY” GRID ﬁeld (grid spacing of 0.5Å)
and its associated descriptors were calculated in Vol-
Surf. Using carefully calibrated energy levels for each MIF
(see Table 6 for details) eight 3D isopotential contours
were computed and condensed to generate 16 descrip-
tors characterizing their volume (V) and integy moment
(Iw).
2.3. Statistical methods
Principal component analysis (PCA) and partial least-squares
(PLS) analysis were performedwith SIMCA-P 11.0. PCA and PLS
models were characterized by the following parameters: the
number of principal components (PC) or latent variables (LV),
the number of compounds n, the coefﬁcient of determinationH H 6.57 6.44
r2, the cross-validated predictive coefﬁcient q2, the standard
deviation s.
2.4. Variables scaling
Due to the distinct nature of descriptors, autoscaling of all
variables to unit variance (UV) has been envisaged. This pro-
cedure gives an equal weight to all variables but one drawback
of such global scaling method is the lack of taking groups of
naturally related descriptors into account. Since UV scaling
will confer more inﬂuence to large groups of variables than
smaller ones for only numerical reasons, it may be relevant
to adjust variables’ scales by adapting their weights based on
prior information about the descriptors. To tackle this prob-
lem a block-scaling method is preferable as it corresponds to
balance the inﬂuence of blocks of variables in relation to their
size (Eriksson et al., 1992). Blockwise scaling was used as it
allows each block to be considered as a unit with an appro-
priate variance. Block scaling can be done in many ways, but
two approaches are widely used, namely hard and soft block
scaling. In soft block scaling, each block of variables is scaled
such that the sum of the variable’s variances equals the fourth
root of the number of variables in the block Nb−1/4. In hard
block scaling, the weight is Nb−1/2. Comparable results were
obtained with both hard and soft block scaling methods. UV
scaling, soft and hard block scaling were investigated con-
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Table 2 – Experimental and calculated afﬁnities of the training set for ﬂavone derivatives, isoﬂavone 39 and chromenone
derivative 34.
.
Cpd Substituent −logKda −logKd
3 5 6 7 8 2′ 3′ 4′ Experimental Calculated
23 OH H H H H H H H 5.00 5.20
24 OH OH H OH H H H H 5.23 4.97
25 OH OH H OH DMA H H H 6.35 6.55
26 OH OH Prenyl OH H H H H 6.68 5.97
27 OH OH H OH Prenyl H H H 6.66 5.99
28 OH OH H OH H H H OH 5.17 4.86
29 OH OH H OH H H H OCH3 5.35 5.03
30 OH OH H OH DMA H H OCH3 6.70 6.29
31 OH OH H OH H H H F 5.17 4.87
32 OH OH H OH H Cl H Cl 5.40 5.68
33 OH OH H OH H H H I 5.96 5.74
34 OH OH H OH H H H H 5.70 6.17
35 OH OH H OH H H H C8H17 7.24 7.40
36 OCH3 OH H OH H H H H 5.05 5.24
37 OCH3 OH H OCH3 DMA H H H 6.82 6.83
38 OH OH H OH H H OH OH 5.15 4.90
39 H OH H OH H H H OH 4.58 5.02
40 H H H H H H H H 4.47 5.30
41 H H H OH H H H H 4.46 5.13
42 OH H H H H H H H 5.00 5.20
43 H OH H OH H H H H 5.05 5.07
44 H OH CH3 OH H H H H 5.51 5.44
45 H OH H OCH3 H H H H 5.20 5.52
46 H OH CH3 OCH3 H H H H 5.89 5.71
47 H OH H OH H H H OH 5.00 4.94
48 H OH H OH H H F F 5.20 5.00
49 H OH H OH H H H I 5.66 5.95
50 H OH H O-iPr H H H H 6.00 6.03
51 H OH iPr OH H H H H 6.68 5.91
52 H OH iPr O-iPr H H H H 6.55 6.68
53 H OH iPr O-iPr iPr H H H 7.48 7.24
54 H OH Bn OH H H H H 6.47 6.38
55 H OH H OH Bn H H H 6.00 6.40
56 H OH Bn OH Bn H H H 7.44 7.49
57 H OH H OBn H H H H 7.17 6.53
58 H OH Prenyl OH H H H H 6.52 6.10
59 H OH H OH DMA H H H 6.70 6.44
60 H OH H OH Prenyl H H H 6.55 6.13
61 H OH Prenyl OH Prenyl H H H 7.82 6.98
62 H OH Geranyl OH H H H 7.35 6.95
63 H OH H OH Geranyl H H H 7.60 6.95
64 H OH H OH DMA H H OH 6.15 6.19
c
p
U
e
(a Taken from Boumendjel et al. (2002a,b).
omitantly and results in using the soft scaling method are
resented in this paper. Shape parameters (V, S, R, G) were
V-scaled and the eight energy levels were block-scaled for
ach MIF (MLPho, MHBPac, MHBPdo, DRY) and each descriptor
volume and integy moment), respectively.3. Results and discussion
In order to evaluate the impact of the descriptors’ distribu-
tion in the 3D linear solvation energy model and identify
258 european journal of pharmaceut ical sc i ences 3 6 ( 2 0 0 9 ) 254–264
Table 3 – Experimental and calculated afﬁnities of the training set for dehydrosylibin derivatives.
.
Cpd Substituent −logKda −logKd
3 4 Experimental Calculated
65 H H 5.66 6.03
66 Prenyl H 6.43 6.79
67 H Prenyl 6.60 6.78
68 Geranyl H 6.74 Not used
69 H Geranyl
a Taken from Boumendjel et al. (2002a,b).
potential outliers, PCA was applied as a ﬁrst step to describe
the chemical space covered by the 89 molecular structures
and their 68 MIFs descriptors. Using the complete dataset
of ﬂavones, chalcones, silybins, aurones, xanthones and 1
isoﬂavone (Boumendjel et al., 2002a,b), a 10 components PCA
model explaining 91% of the original variance was obtained.
The ellipse of Hotelling describing the 95% conﬁdence region
of the model represents a potent tool to point out possible
outliers. Chalcones 13 and 14 and silybin 68 were out of the
Hotelling’s ellipse as presented on the PCA score plot in Fig. 2
(PC1 vs PC2). It might be noticed that ﬂavones 13 and 14 pos-
sess a long alkyl chain that which contributes to their atypical
high molecular size by comparison to other ﬂavonoids. These
three structures were therefore suppressed from the training
set.
A preliminary search for quantitative relationships
between afﬁnity for Pgp and 1D molecular descriptors related
to drug-like properties (Kerns and Di, 2008; Leeson and
Springthorpe, 2007) was performed. No satisfactory models
Table 4 – Experimental and calculated afﬁnities of the training
.
Cpd Substituent
1 2 3 4
70 OH H OCH3 H
71 O-Prenyl H OCH3 H
72 OCH3 H
73 OH H OCH3 H
74 OH H OCH3 Prenyl
75 OH DMA OCH3 H
a Taken from Boumendjel et al. (2002a,b).6.92 7.47
(r2 lower than 0.5; results not shown) were identiﬁed by
linear, multilinear or PLS approaches suggesting that the
parameters used (lipophilicity and H-bonding parameters)
can be modulated by the 3D structure of ﬂavonoids deriva-
tives. Thus the performance of 3D QSAR approaches was
explored.
Another PCA model performed on the 86 remaining com-
pounds indicates a better distribution of the molecular
structures. Based on this training set, a preliminary PLS model
(M1) was built. With one component, this model was not satis-
factory in terms of internal predictive power (q2 = 0.54) mainly
because the calculated afﬁnities for xanthones 71 and 72, and
aurone 78 were largely overestimated by the model (Fig. 3).
For these three compounds the experimental Kd was rang-
ing in the lowest part of experimentally measured values
(logKd < 5). Since the different classes of ﬂavonoid derivatives
were globally correctly predicted, the low correlation achieved
with M1 appears intriguing. A careful examination of their
chemical structure reveals that these three polymethoxylated
set for xanthone and dihydrofuroxanthone derivatives.
−logKda −logKd
7 8 Experimental Calculated
OCH3 OCH3 4.54 5.45
OCH3 OCH3 4.86 Not used
OCH3 OCH3 4.61 Not used
OCH3 OCH3 6.23 6.28
OCH3 OCH3 6.41 6.33
OCH3 OCH3 6.60 6.62
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Table 5 – Experimental and calculated afﬁnities of the training set for aurone derivatives (Z-isomers).
.
Cpd Substituent −logKda −logKd
4 6 2′ 4′ 5′ Experimental Calculated
76 OCH3 OCH3 H CN H 4.70 5.57
77 OCH3 OCH3 H N(CH3)2 H 5.59 6.03
78 OCH3 OCH3 OCH3 OCH3 OCH3 4.04 Not used
79 OH OCH3 H H H 5.88 5.33
80 OH OCH3 H F H 5.57 5.27
81 OH OCH3 H Cl H 6.34 5.77
82 OH OCH3 H Br H 6.82 5.94
83 OH OCH3 H I H 6.59 5.80
84 OH OCH3 H CN H 5.54 5.48
85 OCH3 OCH3 H H H 5.15 5.42
86 OCH3 OCH3 H F H 5.54 5.33
87 OCH3 OCH3 H Cl H 6.00 5.81
88 OCH3 OCH3 H Br H 6.09 6.05
89 OCH OCH H I H 6.27 6.33
c
b
w
a
o
e
w
d
(
t
S
g
e
t
F
n
t
s
f3 3
a Taken from Boumendjel et al. (2002a,b).
ompoundsalsopossess otherhydrophobicmoieties butnoH-
ond donating groups. Presumably hydrophobic interactions
hich dominated the prediction of their Pgp afﬁnity could
lso lower measured afﬁnities by modulating their solubility
r their partitioning. Therefore these three compounds were
xcluded from further analysis.
Thus, a second PLS model (M2) based on 83 compounds
as developed and displayed a satisfactory internal pre-
ictivity (r2 = 0.76; q2 = 0.71; n=83) with 2 latent variables
Fig. 4). PLS coefﬁcients of the M2 model corresponding to
he 3D solvatochromic descriptors are represented in Fig. 5.
hape parameters, i.e. volume (V), surface (S), rugosity (R) and
lobularity (G), hydrophobic volumes (MLPho) and, in lower
xtend, polarizability volumes (DRY) were the main descrip-
ors accounting for the compounds’ afﬁnity towards NBD2.
ig. 1 – Distribution of biological activities expressed as the
egative logarithm of the dissociation constant Kd (M) for
he 5 classes of ﬂavonoid derivatives studied. The drawing
ymbols for the different classes will be conserved in
ollowing ﬁgures.The H-bonding donor potential described by MHBPdo descrip-
tors appeared negligible in comparison to the H-bonding
acceptor capacity represented by MHBPac descriptors. In this
model, MIFs localization–delocalization depicted by Iw had
no signiﬁcant contributions except for the DRY polarizability
MIF. In summary, high afﬁnity for NBD2 was mainly driven
by large hydrophobic volumes and slightly modulated by
the H-bonding acceptor capacity, considering these ﬂavonoid
derivatives.
The reliability of the 3D linear solvation energy model was
also examined for 10 polymethoxylated and polyhydroxylated
ﬂavones reported by Choi et al. (2004) with available exper-
imental Pgp inhibition values expressed in pIC50. The pIC50
values were determined by an in vitro chemosensitizing test in
Pgp over expressing cells resistant to daunorubicin. The bind-
ing afﬁnity (−logKd) of the ﬂavone derivatives were calculated
using the M2 model and compared to their inhibition potency
(experimental pIC50). An interesting relationship could be
highlighted with a determination coefﬁcient r2 of 0.62 and a
Spearman ranking coefﬁcient r2 of 0.67, as reported in Fig. 6.
The satisfactory prediction of inhibitory potency for external
compounds using the 3D QSAR developed to model for the
binding of ﬂavonoids also supports the correlation observed
between Pgp inhibition and experimental NBD2 afﬁnity (Di
Pietro et al., 2002).
These results were conﬁrmed by a preliminary study based
on a multiway N-PLS linear solvation energy analysis. Prior
research demonstrated multiway N-PLS analysis as a robust
and reliable regression method in the context of 3D-QSAR
(Nilsson et al., 1997). This approach allowed building a PLS
model directly on raw MIFs, without the extraction of 1D
descriptors from isopotential contours. In contrast with Vol-
Surf the N-PLS approach requires a preliminary alignment of
the structures. Since the result of the VolSurf model described
above suggested a fuzzy pharmacophore for the afﬁnity of
260 european journal of pharmaceut ical sc i ences 3 6 ( 2 0 0 9 ) 254–264
Fig. 2 – Localization of compounds in PCA score plot (PC1 vs
PC2 projection) of PCA analysis. (A) The 5 classes of
ﬂavonoids derivatives (for symbols, see Fig. 1). (B) Grey
Fig. 3 – Observed vs predicted −logK for PLS model M1 (forcircles: training set used to develop the 3D QSAR model;
black circles: test set of Choi et al.
ﬂavonoids to Pgp, a general alignment procedure was then
used. Indeed, the origin of Cartesian coordinates system was
translated to molecular centre of mass and all molecules were
oriented in the coordinate lattice using the ﬁrst and second
principal inertia axes as, respectively, x and y coordinates
(“ORIENT BEST VIEW” routine of Sybyl). A valuable multiway
N-PLS model was obtained with a cross validation (q2 = 0.73)
Table 6 – MIFs levels used to extract Volsurf parameters.
Level (n) MHBPs
Donor (Dhn) Acceptor (Ah
1 −0.05 −0.02
2 −0.15 −0.04
3 −0.25 −0.11
4 −0.35 −0.18
5 −0.45 −0.26
6 −0.55 −0.34
7 −0.65 −0.4
8 −0.75 −0.5
MHBP and MLP are dimensionless ﬁelds while GRID/Dry are given in kcal/d
symbols, see Fig. 1).
and prediction results (r2 = 0.72) comparable to those obtained
with the VolSurf approach. The convergent results between
the two different methodologies support the validity of the
VolSurfmodel and the relevance of the external test set. These
results also suggest that ﬂavonoids share the same large bind-
ing site for Pgp since a satisfactory N-PLS model was obtained
with the alignment using inertia axes instead of precise
molecular fragments. In addition, the N-PLS approach gave
further information since it also allowed the localization of
key structural regions. The different MIFs areas represented in
Fig. 7 demonstrated that large hydrophobic areas and H-bond
donor potentials are associated with a large favorable role in
NBD2 afﬁnity while polarizability regions and H-bond accep-
tor potentials have lower unfavorable contributions. A deeper
analysis of the H-bonding regions demonstrated that the cho-
sen alignment (and not structure variations) was the main
responsible of PLS signals associated with the two MHBP’s.
According to the N-PLS model (Fig. 7), the difference of afﬁnity
between compound 61 (6,8-diprenylchrysine) and 38 (querce-
MLP GRID
n) Hydrophobic (Hon) Dry (Dn)
−0.15 −0.2
−0.3 −0.4
−0.7 −0.6
−1 −0.8
−1.4 −1
−1.7 −1.2
−2.1 −1.4
−2.5 −1.6
mol.
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Fig. 6 – Observed −logKd vs predicted pIC50 for compoundsig. 4 – Observed vs predicted −logKd for training set
ompounds using PLS model M2 (for symbols, see Fig. 1).
ine) towards NBD2 is mainly due to the substituents located
n the large hydrophobic volume. By these means, prenyla-
ion has been identiﬁed as a positively contributing element
mong a variety of substituents evaluated at several positions.
Wang et al. analyzed a set of 43 ﬂavonoid derivatives (chal-
ones, ﬂavones and silybins) fromKd values forNBD2 collected
rom the literature (Boumendjel et al., 2002b; Di Pietro et al.,
002) using artiﬁcial neural networks (ANNs) and PLS (Wang
t al., 2005). A set of 67 molecular descriptors (e.g. H-bonding
escriptors, lipophilic descriptors and topological descriptors)
as used to describe the molecular structures. The authors
btained some ANN models with internal predictive pow-
rs similar to the 3D QSAR models proposed here. However,
o interpretation in terms of physicochemical properties was
entioned, and no structural information useful to design
ew ﬂavonoids able to bind to Pgp was available from this
ork. Concerning the PLS model, its predictive ability was
ery low (r2 = 0.39), while the training set included less com-
ounds and more descriptors than the 3D linear solvation
nergy model. This low predictive power underlines the weak
apacity of global and topological descriptors used in the study
f Wang et al. (e.g. ﬂexibility index, number of OH groups) to
ncode 3D molecular interactions such as H-bonding forces.
Fig. 5 – PLS coefﬁcients of the PLS modeof the test set calculated with PLS model M2.
Recently, molecular docking was used by Badhan and
Penny (2006) to analyze the binding mode of 24 ﬂavonoid
derivatives with the NBD2 of Pgp (Badhan and Penny, 2006).
This study pointed out the relevant interactions of ﬂavonoids
and analogs with the binding site. The A-ring of chalcones
and the B-ring of ﬂavones are involved in hydrophobic inter-
actions with the Tyr1044 localized in the A-loop preceding the
Walker-A motif (Ambudkar et al., 2006). Concerning H-bond
interactions, only few details were given since few hydrox-
ylated positions were present in the molecular structures
of the dataset. Nevertheless, hydrogen bonds were found
between the carbonyl oxygen of ﬂavonoid derivatives with
Ser1077 and Thr1078 of the Walker-A motif. Therefore, these
docking results partially support the positive contribution of
hydrophobicity underlined by the 3D QSAR models described
here. Especially, the N-PLS approach pointed out the contri-
bution of prenylation at the 6- and 8-position in compound 61
(6,8-diprenylchrysine, Fig. 7). The localizationof thehydropho-
bic ﬁeld induced by this substituent is also consistent with
reduced docking energies found by Badhan and Penny (2006)
after prenylation of chrysine in these positions. This result
suggested a favorable inﬂuence in afﬁnity to NBD2 domain.
l M2 (see text for MIFs deﬁnitions).
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Fig. 7 – N-PLS coefﬁcients with 6,8-diprenylchrysine (left) and quercetine (right) for hydrophobic (green), polarizability
ntia
e for(yellow), H-bond donor (red) and H-bond acceptor (blue) pote
hydrophobic and H-bond donor interactions and unfavorabl
Furthermore previous qualitative structure–activity anal-
yses reported that MDR-modulating activity of ﬂavonoid
derivatives was partially governed by their lipophilicity (Ferté
et al., 1999). The best MDR modulation obtained by C-
prenylation, O-prenylation and methoxylation of ﬂavonoids
(Barron et al., 2003; Choi et al., 2004) are in agreement with
the positive contribution of hydrophobicity. Nevertheless, the
favorable effect of methoxylation could also be interpreted
as a favorable contribution of H-bonding-acceptor capacity.
Therefore, in addition to hydrophobic ﬁeld, 3D-QSAR meth-
ods allow to precise the role of H-bonding ﬁelds for the
substituents linked to the ﬂavonoidic-scaffold in the Pgp bind-
ing. The latter has been considered as an ATP-mimic and
conﬁrmed by crystallography studies in a variety of ATP-
dependent key enzymes and proteins. The inhibitory activity
is believed to be due to their ability to act as ATP-competitive
inhibitors and it has been postulated that ﬂavonoids activity
is due at least in part to the ability of the benzopyran moi-
ety (chromenone) to mimic the adenine of ATP. The recent
high-resolution structure of cyclin-dependent protein kinase2
(CDK2) co-crystallized with a eight-substituted derivative of
chrysin (5,7-dihydroxyﬂavone), L868276 has come to reinforce
the ATP-mimicry hypothesis (deAzevedo et al., 1996). In the
crystal structure, the 5-hydroxyl of L868276 is shown to inter-
act with as many as ﬁve residues normally interacting with
the 6-amino group of the adenine moiety of ATP, whereas
the vicinal 4-carbonyl of L868276 appears equivalent to the
1-nitrogen atom of adenine. The role played by the A/C rings
of quercitin in mimicking the adenine moiety of nucleotide
ATP has been conﬁrmed by co-crystallisation of quercetin
with tyrosine kinase Hck (Sicheri et al., 1997). Recently, co-
crysallisation data was explored in docking studies related to
ﬂavonoid interactions with ATP-dependent enzymes (Lu et al.,
2005). Since Pgp is anATP-dependent protein,we canhypothe-
size that our compounds induce their activity throughadenine
mimicry.
The 3D linear solvation energy analysis presented here
pointed out to the strong inﬂuence of the parameters relatedl. The coefﬁcients are favorable for the binding to PgP for
polarizability and H-bond acceptor interactions.
to molecular shape and hydrophobicity on the strength of
binding, modulated by H-bonding acceptor and donor abil-
ities. It is worthwhile mentioning that the physicochemical
properties identiﬁed are consistent with previous studies aris-
ing from qualitative-structure activity studies (Ha et al., 2007).
Moreover and unlike structure–activity analysis, the 3D QSAR
method is able to distinguish between the part of hydropho-
bicity and the part of H-bonding capacity of lipophilicity for
O-alkyl substituent. The favorable role of O-prenylation and
methoxylation observed on ﬂavonoids could be attributed to
their hydrophobicity rather than to their H-bonding-acceptor
capacity. In addition, the good prediction of inhibitory poten-
cies of ﬂavonoid derivatives by the model conﬁrmed the
interest of this 3D linear solvation energy approach.
4. Conclusion
The large inﬂuence of Pgp activity on pharmacokinetics and
on the failure of anti-cancer therapy requires the development
of effective inhibitors. Hence, it was relevant to investigate the
molecular interactions of Pgp-modulators. In this context, the
3D linear solvation energy approach offers a novel and potent
in silico method to perform 3D-QSAR analysis of pharmaco-
dynamic properties. The method produced a reliable in silico
model, based on four MIFs, which is able to predict the afﬁnity
of ﬂavonoid derivatives towards the NBD2 cytosolic domain
of Pgp and identify the main molecular properties governing
this interaction. Actually, the 3D QSAR analysis conﬁrmed the
positive contribution of hydrophobicity and underlined the
positive impact of shape parameters. Accordingly, H-bonding
ability appeared as a modulating contribution. These physico-
chemical features can assist and accelerate the design of new
potent chemosensitizers andhigher size, bifunctional, speciﬁc
inhibitors by cross linking such an ATP-competitive ﬂavonoid
derivative to a substrate- or modulator-drug derivatives.
It should be noticed that, as yet, the 3D linear solvation
energy method has never been applied to prediction of phar-
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acodynamic process as the afﬁnity to Pgp, a phenomenon
trongly inﬂuenced by the physicochemical parameters, but
nly to thepredictionof physiological barrier permeation. This
uccessful application to the characterization of descriptors
elated to pharmacodynamic properties revealed some novel
erspectives for a method designed to study pharmacokinetic
roﬁles of drugs. The reported results are being explored in
he design of new ligands for Pgp and other ABC proteins
ocusing especially on the positive effect of hydrophobic of
ubstituents at 6- and 8-position in the design of new ABC
roteins inhibitors.
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